405 related articles for article (PubMed ID: 15477536)
1. Hyperinsulinemia and risk of Alzheimer disease.
Luchsinger JA; Tang MX; Shea S; Mayeux R
Neurology; 2004 Oct; 63(7):1187-92. PubMed ID: 15477536
[TBL] [Abstract][Full Text] [Related]
2. Plasma homocysteine levels and risk of Alzheimer disease.
Luchsinger JA; Tang MX; Shea S; Miller J; Green R; Mayeux R
Neurology; 2004 Jun; 62(11):1972-6. PubMed ID: 15184599
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.
Xu WL; Qiu CX; Wahlin A; Winblad B; Fratiglioni L
Neurology; 2004 Oct; 63(7):1181-6. PubMed ID: 15477535
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.
van Himbergen TM; Beiser AS; Ai M; Seshadri S; Otokozawa S; Au R; Thongtang N; Wolf PA; Schaefer EJ
Arch Neurol; 2012 May; 69(5):594-600. PubMed ID: 22213409
[TBL] [Abstract][Full Text] [Related]
5. Hyperinsulinemia and cognitive decline in a middle-aged cohort.
Young SE; Mainous AG; Carnemolla M
Diabetes Care; 2006 Dec; 29(12):2688-93. PubMed ID: 17130206
[TBL] [Abstract][Full Text] [Related]
6. Association of dietary cholesterol and egg intakes with the risk of incident dementia or Alzheimer disease: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Ylilauri MP; Voutilainen S; Lönnroos E; Mursu J; Virtanen HE; Koskinen TT; Salonen JT; Tuomainen TP; Virtanen JK
Am J Clin Nutr; 2017 Feb; 105(2):476-484. PubMed ID: 28052883
[TBL] [Abstract][Full Text] [Related]
7. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
8. Alcohol intake and risk of dementia.
Luchsinger JA; Tang MX; Siddiqui M; Shea S; Mayeux R
J Am Geriatr Soc; 2004 Apr; 52(4):540-6. PubMed ID: 15066068
[TBL] [Abstract][Full Text] [Related]
9. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
Seshadri S; Beiser A; Selhub J; Jacques PF; Rosenberg IH; D'Agostino RB; Wilson PW; Wolf PA
N Engl J Med; 2002 Feb; 346(7):476-83. PubMed ID: 11844848
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
11. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I receptor stimulating activity is associated with dementia.
de Bruijn RF; Janssen JA; Brugts MP; van Duijn CM; Hofman A; Koudstaal PJ; Ikram MA
J Alzheimers Dis; 2014; 42(1):137-42. PubMed ID: 24820016
[TBL] [Abstract][Full Text] [Related]
13. Risk of Alzheimer's disease or dementia following a cancer diagnosis.
Bowles EJA; Walker RL; Anderson ML; Dublin S; Crane PK; Larson EB
PLoS One; 2017; 12(6):e0179857. PubMed ID: 28632787
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and the Risk of Dementia: The Rotterdam Study.
Licher S; de Bruijn RFAG; Wolters FJ; Zillikens MC; Ikram MA; Ikram MK
J Alzheimers Dis; 2017; 60(3):989-997. PubMed ID: 28984598
[TBL] [Abstract][Full Text] [Related]
15. Association Between Serum β-Alanine and Risk of Dementia.
Hata J; Ohara T; Katakura Y; Shimizu K; Yamashita S; Yoshida D; Honda T; Hirakawa Y; Shibata M; Sakata S; Kitazono T; Kuhara S; Ninomiya T
Am J Epidemiol; 2019 Sep; 188(9):1637-1645. PubMed ID: 31127276
[TBL] [Abstract][Full Text] [Related]
16. Low serum insulin-like growth factor-I (IGF-I) level is associated with increased risk of vascular dementia.
Quinlan P; Horvath A; Nordlund A; Wallin A; Svensson J
Psychoneuroendocrinology; 2017 Dec; 86():169-175. PubMed ID: 28963885
[TBL] [Abstract][Full Text] [Related]
17. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
[TBL] [Abstract][Full Text] [Related]
18. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.
Tan ZS; Seshadri S; Beiser A; Wilson PW; Kiel DP; Tocco M; D'Agostino RB; Wolf PA
Arch Intern Med; 2003 May; 163(9):1053-7. PubMed ID: 12742802
[TBL] [Abstract][Full Text] [Related]
19. Impaired insulin secretion increases the risk of Alzheimer disease.
Rönnemaa E; Zethelius B; Sundelöf J; Sundström J; Degerman-Gunnarsson M; Berne C; Lannfelt L; Kilander L
Neurology; 2008 Sep; 71(14):1065-71. PubMed ID: 18401020
[TBL] [Abstract][Full Text] [Related]
20. Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.
Neergaard JS; Dragsbæk K; Christiansen C; Karsdal MA; Brix S; Henriksen K
PLoS One; 2018; 13(4):e0194802. PubMed ID: 29641555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
